• BioRestorative Therapies named Lance Alstodt chairman, chief executive officer, and president under an executive employment agreement dated May 27, 2026.
• Alstodt will report to the board of directors.
• The agreement sets an initial three-year term with automatic one-year renewals unless either side gives notice at least 90 days before expiry.
• It also outlines severance terms tied to termination without cause, resignation for good reason, or a change in control.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001021771-26-000084), on May 29, 2026, and is solely responsible for the information contained therein.